Ervexia Occupational Health Ervexia

The vendor opportunity at Ervexia Occupational Health

Ervexia Occupational Health is a financial services franchise operating in the occupational health space, headquartered in Arizona. With only 3 total units—1 franchised and 2 company-owned—the addressable market for software vendors is extremely small. The system reported an average unit volume (AUV) of $892,824 in the 2026 FDD, which suggests healthy per-unit economics despite the tiny footprint. Year-over-year unit growth was -50%, indicating contraction rather than expansion. For a software vendor, this is a low-volume target, but the high AUV and 8% royalty rate signal that the existing units are generating meaningful revenue and likely have operational needs that software could address.

Who controls software purchasing

The 2026 FDD lists two key executives: Dr. Don Maple, President of Clinical Services, and Dr. Dallas Humble, President of Operations. In a system this small, these two individuals almost certainly control or heavily influence all software purchasing decisions. There is no CIO, CTO, or dedicated IT buyer named in the FDD. Vendors should approach Dr. Maple for clinical-adjacent tools and Dr. Humble for operational or back-office solutions. Because the franchisor operates two company-owned units alongside a single franchisee, the HQ team likely sets technology standards that the franchisee must follow, making HQ the sole decision-making center.

Mandated and current tech stack

The only technology system explicitly mandated in the 2026 FDD is Pass My Physical. No other POS, scheduling, EHR, billing, or compliance platforms are named as required or recommended. This creates a potential opening for vendors offering complementary solutions—such as patient engagement, billing, or workforce management—provided they can demonstrate integration with Pass My Physical. The absence of a broad mandated stack means the franchisee may have some discretion, but given the HQ-controlled structure, any sale would almost certainly need buy-in from Dr. Maple or Dr. Humble.

Procurement, renewals, and timing

Procurement details are sparse in this FDD. Item 8, which typically describes designated or approved supplier programs, contains no extract, meaning the franchisor does not publicly disclose a formal procurement framework. Similarly, Item 17—covering renewal, termination, and transfer—offers no extract, so the initial term length and renewal windows are unknown. This lack of transparency makes it difficult to time a sales outreach around contract cycles. Vendors should assume an open, relationship-driven procurement process and focus on building direct connections with the two named executives.

How to read the Ervexia Occupational Health FDD

The 2026 Franchise Disclosure Document for Ervexia Occupational Health is embedded below for full review. It was filed with state franchise regulators and contains the legal and financial disclosures required under the FTC Franchise Rule. Key sections for software vendors include Item 1 (the franchisor and its executives), Item 11 (mandated technology and suppliers), Item 8 (procurement restrictions), and Item 17 (renewal and termination terms). Given the small size of this system, the FDD is the most reliable source for understanding the decision-making structure and technology requirements before initiating contact. For a ranked target list of franchise systems matched to your software category, reach out to FranCloud.